Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
Guidelines to Practice

Hyperglycemic crises in adults: A look at the 2024 consensus report

Paloma Rodriguez Alvarez, MD, Vicente T. San Martin, MD and Oscar L. Morey-Vargas, MD
Cleveland Clinic Journal of Medicine March 2025, 92 (3) 152-158; DOI: https://doi.org/10.3949/ccjm.92a.24089
Paloma Rodriguez Alvarez
Department of Endocrinology, Diabetes, and Metabolism, Cleveland Clinic, Cleveland, OH; Visiting Assistant Professor, Department of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: [email protected]
Vicente T. San Martin
Department of Endocrinology and Diabetes, Macromédica Dominicana, Santo Domingo, Dominican Republic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Oscar L. Morey-Vargas
Director of Inpatient Diabetes Service, Department of Endocrinology, Diabetes, and Metabolism, Cleveland Clinic, Cleveland, OH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Find this author on Cleveland Clinic
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Tables

    • View popup
    TABLE 1

    2024 consensus report criteria for resolution of diabetic ketoacidosis and hyperglycemic hyperosmolar state

    Resolution criteria5
    Diabetic ketoacidosisHyperglycemic hyperosmolar state
    Plasma or capillary beta-hydroxybutyrate < 0.6 mmol/L
    AND
    Venous pH ≥ 7.3
    OR
    Bicarbonate ≥ 18 mmol/L
    Serum osmolality < 300 mOsm/kg
    AND
    Blood glucose < 250 mg/dL
    AND
    Urine output > 0.5 mL/kg/hour
    AND
    Cognitive status improved
    • View popup
    TABLE 2

    Changes in diabetic ketoacidosis diagnostic criteria between 2009 consensus statement and 2024 consensus report

    Diagnostic criteria2009 Consensus statement42024 Consensus report5
    Plasma glucose (D criterion)Glucose > 250 mg/dLGlucose ≥ 200 mg/dL
    OR
    History of diabetes, irrespective of the presenting glucose value
    Ketosis (K criterion)Serum ketones: positive
    Urine ketones: positive
    Beta-hydroxybutyrate ≥ 3 mmol/L
    OR
    Urine ketone strip ≥ 2+
    Metabolic acidosis (A criterion)pH ≤ 7.3
    Bicarbonate ≤ 18 mmol/L
    Anion gap > 10
    pH < 7.3 with or without bicarbonate < 18 mmol/L
    Anion gap was removed as a diagnostic criterion
    • View popup
    TABLE 3

    Changes in hyperglycemic hyperosmotic state diagnostic criteria between 2009 consensus statement and 2024 consensus report

    Diagnostic criteria2009 Consensus statement42024 Consensus report5
    HyperglycemiaPlasma glucose > 600 mg/dLPlasma glucose ≥ 600 mg/dL
    HyperosmolalityCalculated effective serum osmolality
    > 320 mOsm/kg
    Calculated osmolality:
    Effectivea > 300 mOsm/kg
    OR
    Totalb > 320 mOsm/kg
    Absence of significant ketosisSerum ketones: Small
    Urine ketones: Small
    Beta-hydroxybutyrate < 3 mmol/L
    OR
    Urine ketones < 2+
    Absence of significant acidosispH > 7.3
    Bicarbonate > 18 mmol/L
    pH ≥ 7.3
    AND
    Bicarbonate ≥ 15 mmol/L
    Mental statusStupor or comaRemoved as a diagnostic criterion
    • ↵aEffective osmolality calculated as 2[sodium (mmol/L)] + glucose (mmol/L)

    • ↵bTotal osmolality calculated as 2[sodium (mmol/L)] + glucose (mmol/L) + urea (mmol/L)

    • View popup
    TABLE 4

    Main changes in treatment recommendations between 2009 consensus statement and 2024 consensus report

    2009 Consensus statement42024 Consensus report5
    FluidsTypeIsotonic saline (0.9% NaCl) during the first hour
    Subsequently, use 0.45% NaCl if serum sodium is high or normal; continue 0.9% NaCl if serum sodium is low
    Change to dextrose 5% with 0.45% NaCl when glucose reaches 200 mg/dL in DKA and 300 mg/dL in HHS
    Isotonic saline or balanced crystalloid solutions, with subsequent choice of fluids depending on fluid balance, hemodynamics, and sodium concentration
    0.45% NaCl is indicated only if osmolality is not declining in HHS despite adequate fluid and insulin therapy
    Add dextrose 5% or 10% when glucose reaches < 250 mg/dL for both DKA and HHS
    Volume15–20 mL/kg/hour or 1–1.5 L in the first hour
    Subsequently, 250–500 mL/hour
    500–1,000 mL/hour during the first 2–4 hours
    Subsequently, adjust rate as clinically appropriate
    Time to correction of estimated fluid deficit24 hours24–48 hours (replace 50% of fluid deficit in the first 8–12 hours)
    InsulinInitialBoth DKA and HHS:
    0.1 units/kg in IV bolus, followed by FRIII at
    0.1 units/kg/hour
    OR
    FRIII at 0.14 units/kg/hour
    Moderate and severe DKA:
    FRIII at 0.1 units/kg/hour (consider 0.1 units/kg
    IV bolus if IV access is delayed)
    OR
    Nurse-driven insulin infusion protocol
    Mild and moderate DKA:
    Subcutaneous rapid-acting insulin analogue
    0.1 units/kg every 1 hour or 0.2 units/kg every 2 hours
    HHS: FRIII at 0.05 units/kg/hour
    Mixed DKA/HHS: treat as DKA
    Initial glucose goal for dextrose initiationDKA: < 200 mg/dL
    HHS: < 300 mg/dL
    DKA and HHS: < 250 mg/dL
    Maintenance after dextrose initiationDecrease infusion to 0.02–0.05 units/kg/hour until resolutionDecrease infusion to 0.05 units/kg/hour until resolution
    Glucose goal until resolutionDKA: 150–200 mg/dL
    HHS: 200–300 mg/dL
    DKA: 150–200 mg/dL
    HHS: 200–250 mg/dL
    PotassiumLow< 3.3 mmol/L: give 20–30 mmol/hour and postpone insulin therapy until serum potassium > 3.3 mmol/L< 3.5 mmol/L: give 10–20 mmol/hour and postpone insulin therapy until serum potassium > 3.5 mmol/L
    Normal3.3–5.2 mmol/L: give 20–30 mmol in each liter of IV fluid to maintain serum potassium of 4–5 mmol/L3.5–5.0 mmol/L: give 10–20 mmol in each liter of IV fluid to maintain serum potassium of 4–5 mmol/L
    High> 5.2 mmol/L: do not give potassium but check serum potassium every 2 hours> 5.0 mmol/L: do not give potassium but check serum potassium every 2 hours
    • DKA = diabetic ketoacidosis; FRIII = fixed-rate intravenous insulin infusion; HHS = hyperglycemic hyperosmolar state; IV = intravenous

PreviousNext
Back to top

In this issue

Cleveland Clinic Journal of Medicine: 92 (3)
Cleveland Clinic Journal of Medicine
Vol. 92, Issue 3
1 Mar 2025
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Cleveland Clinic Journal of Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Hyperglycemic crises in adults: A look at the 2024 consensus report
(Your Name) has sent you a message from Cleveland Clinic Journal of Medicine
(Your Name) thought you would like to see the Cleveland Clinic Journal of Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Hyperglycemic crises in adults: A look at the 2024 consensus report
Paloma Rodriguez Alvarez, Vicente T. San Martin, Oscar L. Morey-Vargas
Cleveland Clinic Journal of Medicine Mar 2025, 92 (3) 152-158; DOI: 10.3949/ccjm.92a.24089

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Hyperglycemic crises in adults: A look at the 2024 consensus report
Paloma Rodriguez Alvarez, Vicente T. San Martin, Oscar L. Morey-Vargas
Cleveland Clinic Journal of Medicine Mar 2025, 92 (3) 152-158; DOI: 10.3949/ccjm.92a.24089
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Linkedin Share Button

Jump to section

  • Article
    • ABSTRACT
    • WHO WROTE THE CONSENSUS REPORT?
    • WHAT ARE THE MAIN RECOMMENDATIONS?
    • WHAT IS DIFFERENT FROM PREVIOUS GUIDELINES?
    • HOW WILL THE NEW CONSENSUS CHANGE DAILY PRACTICE?
    • DISCLOSURES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • In defense of the anion gap
  • In Reply: In defense of the anion gap
  • Google Scholar

More in this TOC Section

  • New atrial fibrillation guideline: Modify risk, control rhythm, prevent progression
  • 2024 ACC/AHA guideline on perioperative cardiovascular management before noncardiac surgery: What’s new?
Show more Guidelines to Practice

Similar Articles

Subjects

  • Diabetes
  • Endocrinology

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2025 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire